Trial intelligence / Profile preview

Acute Effect of Indacaterol Maleate on Lung Volume in COPD

NCT01377051Phase 4Completed

Sponsor
University of Milan
Start
May 2011
Primary completion
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of indacaterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University of Milan. Primary endpoint: Intra Thoracic Gas Volume. Started May 2011; status: completed.

02

Drugs

indacaterol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01377051.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01377051.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call